KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 99 filers reported holding KYMERA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $518,887 | -52.5% | 37,330 | -21.4% | 0.00% | 0.0% |
| Q2 2023 | $1,091,542 | +4.3% | 47,479 | +34.4% | 0.00% | 0.0% |
| Q1 2023 | $1,046,858 | +30.0% | 35,331 | +9.5% | 0.00% | 0.0% |
| Q4 2022 | $805,335 | +16.9% | 32,265 | +2.1% | 0.00% | 0.0% |
| Q3 2022 | $689,000 | +50.8% | 31,608 | +36.0% | 0.00% | – |
| Q2 2022 | $457,000 | -53.7% | 23,244 | -0.3% | 0.00% | -100.0% |
| Q1 2022 | $987,000 | -20.5% | 23,305 | +19.1% | 0.00% | 0.0% |
| Q4 2021 | $1,242,000 | +27.4% | 19,570 | +17.9% | 0.00% | 0.0% |
| Q3 2021 | $975,000 | +200.9% | 16,597 | +148.0% | 0.00% | – |
| Q2 2021 | $324,000 | -14.7% | 6,691 | -31.6% | 0.00% | – |
| Q1 2021 | $380,000 | -43.9% | 9,784 | -10.4% | 0.00% | – |
| Q4 2020 | $677,000 | – | 10,917 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 457,059 | $9,950,000 | 17.03% |
| Atlas Venture Life Science Advisors, LLC | 6,875,698 | $149,684,000 | 16.52% |
| BVF INC/IL | 4,692,604 | $102,158,000 | 4.22% |
| Aquilo Capital Management, LLC | 330,246 | $7,189,000 | 2.59% |
| Redmile Group, LLC | 2,876,637 | $62,624,000 | 2.43% |
| Artal Group S.A. | 1,500,000 | $32,655,000 | 1.39% |
| Deer Management Co. LLC | 615,895 | $13,408,000 | 0.94% |
| Avoro Capital Advisors LLC | 2,169,230 | $47,224,000 | 0.87% |
| AtonRa Partners | 34,462 | $750,000 | 0.74% |
| Rock Springs Capital Management LP | 1,046,743 | $22,788,000 | 0.59% |